Pharmacokinetics of ticarcillin and clavulanic acid (timentin) in relation to renal function
- PMID: 3492959
- PMCID: PMC180615
- DOI: 10.1128/AAC.30.6.896
Pharmacokinetics of ticarcillin and clavulanic acid (timentin) in relation to renal function
Abstract
The disposition of coadministered ticarcillin (3 g/1.73 m2) and clavulanic acid (100 mg/1.73 m2) was examined after a 30-min infusion in 24 noninfected subjects with various degrees of renal function. Noncompartmental pharmacokinetic parameters for the individual compounds were determined from plasma concentrations and urinary excretion rates. All clearances (total, renal, and nonrenal) and urinary recoveries of unchanged drug were found to be linearly related to creatinine clearance (CLCR). The steady-state volume of distribution (9.9 and 12.9 liters for ticarcillin and clavulanic acid) approximated the extracellular fluid space and was not related to CLCR. The half-lives increased with reduced renal function and ranged from 56 to 392 min for ticarcillin and 26 to 266 min for clavulanic acid. The clearances of both drugs decreased proportionately with reduction in renal function, facilitating dosing adjustments based on CLCR. Calculations of expected steady-state maximum and minimum concentrations in plasma using constant doses and an extended dosing interval related to CLCR further rationalized use of the 30:1 drug combination ratio for all patients.
Similar articles
-
The pharmacokinetics of ticarcillin, clavulanic acid and their combination.J Antimicrob Chemother. 1986 May;17 Suppl C:47-55. doi: 10.1093/jac/17.suppl_c.47. J Antimicrob Chemother. 1986. PMID: 3722046
-
Pharmacokinetics of the combination of ticarcillin with clavulanic acid in renal insufficiency.J Antimicrob Chemother. 1986 May;17 Suppl C:57-64. doi: 10.1093/jac/17.suppl_c.57. J Antimicrob Chemother. 1986. PMID: 3722047
-
Pharmacokinetics of parenteral ticarcillin formulated with clavulanic acid: Timentin.Int J Clin Pharmacol Ther Toxicol. 1986 Mar;24(3):123-9. Int J Clin Pharmacol Ther Toxicol. 1986. PMID: 3699938
-
Rational prescribing of extended-spectrum penicillin beta-lactamase inhibitor combinations: focus on ticarcillin/clavulanic acid.Ann Pharmacother. 1998 Jan;32(1):S17-21. doi: 10.1177/106002809803200105. Ann Pharmacother. 1998. PMID: 9475835 Review.
-
Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance.Infect Control. 1987 Jan;8(1):36-40. doi: 10.1017/s0195941700066972. Infect Control. 1987. PMID: 3028975 Review.
Cited by
-
Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.Clin Pharmacokinet. 1988 Sep;15(3):133-64. doi: 10.2165/00003088-198815030-00001. Clin Pharmacokinet. 1988. PMID: 3052984 Review.
-
Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria.Ann Pharmacother. 2009 Jul;43(7):1324-37. doi: 10.1345/aph.1L638. Epub 2009 Jul 7. Ann Pharmacother. 2009. PMID: 19584386 Free PMC article. Review.
-
Pharmacokinetics of amoxycillin and clavulanic acid in haemodialysis patients following intravenous administration of Augmentin.Br J Clin Pharmacol. 1988 Oct;26(4):385-90. doi: 10.1111/j.1365-2125.1988.tb03395.x. Br J Clin Pharmacol. 1988. PMID: 3190988 Free PMC article.
-
Pilot study of side effects and serum and urine concentrations of amoxicillin-clavulanic acid in azotemic and non-azotemic cats.J Feline Med Surg. 2020 Aug;22(8):729-735. doi: 10.1177/1098612X19881537. Epub 2019 Oct 29. J Feline Med Surg. 2020. PMID: 31660773 Free PMC article.
-
Clinical pharmacokinetics of antibiotics in patients with impaired renal function.Clin Pharmacokinet. 1992 Mar;22(3):169-210. doi: 10.2165/00003088-199222030-00002. Clin Pharmacokinet. 1992. PMID: 1559311 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases